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Hospital Pharmacists’ Views on Collaborative 
Pharmacist Prescribing
In 2008, Weeks et al.1 published the results of a postal 
survey, which explored the views of the Society of 
Hospital Pharmacists of Australia’s (SHPA) members 
on collaborative prescribing, and the extent of de facto 
prescribing in their institution. Since then, signifi cant 
work has been undertaken on non-medical prescribing, 
such as pilots of pharmacist prescribing across Australia 
and a National Health Workforce report on developing 
a nationally consistent approach to prescribing by non-
medical health professionals.2,3 The fi rst stage of the Health 
Workforce Australia Health Practitioner Prescribing 
Pathway project is complete and the recommendations 
for implementation have been approved by the Standing 
Council in November 2013.4 New Zealand pharmacists 
obtained prescribing rights in 2013, and the fi rst cohort 
of 14 prescribers have completed the postgraduate 
pharmacist prescribing course (jointly run by the Otago 
and Auckland Universities).5 
At the 39th SHPA national conference (19 to 22 
September 2013), the Saturday breakfast session (‘Piecing 
together the pharmacist prescribing puzzle – more than 
just paper and pills’) gave an overview of results from an 
Australian prescribing pilot, the collaboration between 
Australia and New Zealand and Australia’s current 
position in the pharmacist prescribing agenda. To make 
the session interactive, seven questions were interspersed 
throughout the presentation for the audience to answer via 
a smart phone application. Five questions from the Weeks 
et al.1 (2008) survey were utilised (to compare results) 
and two new questions were added (to ascertain opinions 
on educational requirements for pharmacist prescribers). 
The  2008 survey elicited 551 responses, while at the 
conference there were 86 to 98 respondents. 
In 2008, 95% of respondents compared to 98% (p = 
0.4, exact) at the conference had witnessed system delays 
or pressure points where they believed collaborative 
prescribing could assist service delivery. The defi nition of 
de fact’ prescribing used in the 2008 paper was provided 
to the audience prior to question 2, namely ‘initiation, 
cessation, transcription, amendment or per-protocol 
change of a medication order, excluding verbal orders 
from medical practitioners’. In 2008, 37% of pharmacists 
thought they were de facto prescribing compared to 84% in 
2013 (p < 0.001; chi-square). This suggests there has either 
been an increase in the number of pharmacists taking on 
extended roles in the last 5 years or pharmacists are now 
more aware that the tasks they have always done could be 
classed as de facto prescribing. A higher proportion in 2013 
(85%) would consider becoming a prescriber in a clinical 
area if there was a legal and credentialing framework 
compared to 75% in 2008 (p = 0.04; chi-square). This is 
encouraging, as there were concerns that low numbers 
would potentially make a prescribing course diffi cult to 
sustain. Similar proportions of respondents thought that a 
prescribing role was important for the future development 
of clinical pharmacy practice; 79% in 2013 versus 77% in 
2008 (p = 0.72; chi-square). A lower proportion in 2013 
(57%) compared to 71% in 2008 (p = 0.007; chi-square) 
thought that the emergence of a prescribing role was 
important to attract and retain hospital pharmacists.
The audience were presented training requirements 
from UK and New Zealand, and asked how many years 
of workplace experience should pharmacists have before 
being eligible to undertake a postgraduate prescribing 
course? The majority favoured a time period of more than 2 
years, supporting the proposal that pharmacist prescribing 
be an ‘advanced practitioner’ role; 9% suggested 
prescribing should be taught at an undergraduate level, 
3% thought pharmacists with 0 to 2 years experience, 
48%  believed 2 to 5 years was appropriate, and 39% 
suggested that more than 5 years was necessary. Opinions 
on the study burden of the New Zealand course were also 
investigated; 76% agreed that it was ‘just right’, 7% that 
more study was required and 17% opined the burden 
was too high. This is reassuring, because the majority 
of respondents (83%) would undertake signifi cant extra 
training to be able to take on a prescribing role. Experience 
suggests that one of the biggest challenges the profession 
faces is the paradigm shift from reviewer to prescriber of 
medicines, and the realisation of the different mindset and 
competencies required for this new role. This needs to be 
addressed as part of any future prescribing course.
Barriers to the set up and running of pharmacist 
prescribing pilots in Queensland were presented and 
the solutions were used to describe what the research 
team believe are facilitators to successfully progress 
the pharmacist prescribing agenda in Australia. The 
facilitators included:
• a senior ‘advanced level’ clinician with appropriate 
postgraduate qualifi cations
• accredited prescribing training to satisfy concerns 
over competence to prescribe
• recruitment of supportive, senior medical staff prior 
to commencement of the pilots, to be responsible for 
sign off of prescribing competencies and supervision
• clear collaborative scopes of practice that had been 
agreed with the appropriate senior medical staff
• clear proposed outcomes and benefi ts of the service, 
with an emphasis on freeing up doctor time, and 
better utilisation of skills within the existing 
multidisciplinary team
• overarching principle of providing patients with 
access to safe and appropriate medication usage. 
Future proposed scopes of practice and prescribing 
models for pharmacists to operate within as prescribers, 
need to be mindful of these requirements to ensure the best 
chance of success.
A unifi ed approach from the entire pharmacy 
profession is essential, with agreement on proposed 
models of care, scopes of practice, and training and 
education requirements to sustainably produce competent 
prescribers. Without this, progression of the new role, 
and ensuring the knowledge and skills of pharmacists are 
utilised to their full potential, will be a major challenge.
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